C000005587 Holdings — Blackrock Eurofund
All 49 reported holdings of Blackrock Eurofund (C000005587) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Euro | 8.16% | $8.61M |
| Taiwan Semiconductor Manufacturing Co. Ltd. | 6.58% | $6.94M |
| Siemens Energy AG | 4.34% | $4.58M |
| Lloyds Banking Group plc | 4.10% | $4.33M |
| UniCredit SpA | 3.88% | $4.10M |
| Mastercard, Inc. | 3.72% | $3.93M |
| Advantest Corp. | 3.57% | $3.77M |
| ABN AMRO Bank NV | 3.55% | $3.75M |
| Engie SA | 3.52% | $3.72M |
| AIB Group plc | 3.40% | $3.59M |
| Safran SA | 3.29% | $3.48M |
| ASML Holding NV | 3.28% | $3.46M |
| Hitachi Ltd. | 3.12% | $3.29M |
| MTU Aero Engines AG | 2.99% | $3.16M |
| BE Semiconductor Industries NV | 2.66% | $2.81M |
| Erste Group Bank AG | 2.58% | $2.72M |
| Talanx AG | 2.46% | $2.59M |
| Mitsubishi UFJ Financial Group, Inc. | 2.44% | $2.58M |
| Kone OYJ | 2.29% | $2.42M |
| CaixaBank SA | 2.22% | $2.34M |
| Thales SA | 2.17% | $2.29M |
| Intesa Sanpaolo SpA | 2.05% | $2.17M |
| Belimo Holding AG | 2.05% | $2.16M |
| Airbus SE | 2.04% | $2.15M |
| Ucb SA | 2.02% | $2.13M |
| Novartis AG | 1.91% | $2.02M |
| Galderma Group AG | 1.86% | $1.97M |
| Sandvik AB | 1.52% | $1.61M |
| TotalEnergies SE | 1.33% | $1.40M |
| ABB Ltd. | 1.25% | $1.32M |
| Chemometec A/S | 1.18% | $1.25M |
| NatWest Group plc | 1.16% | $1.23M |
| Sap SE | 1.13% | $1.19M |
| ASM International NV | 1.09% | $1.15M |
| Kongsberg Gruppen ASA | 1.06% | $1.12M |
| Weir Group plc (The) | 0.98% | $1.03M |
| Cie Financiere Richemont SA | 0.96% | $1.01M |
| 3i Group plc | 0.93% | $977.60K |
| Sea Ltd. | 0.86% | $909.75K |
| BlackRock Liquidity Funds | 0.45% | $470.73K |
| Adyen NV | 0.18% | $192.16K |
| SMG Swiss Marketplace Group AG | 0.17% | $183.32K |
| New Taiwan Dollar | 0.00% | $-0 |
| Yen | 0.00% | $47 |
| Swedish Krona | 0.00% | $0 |
| Danish Krone | 0.00% | $38 |
| Won | 0.00% | $22 |
| Swiss Franc | 0.00% | $1 |
| Pound Sterling | 0.00% | $-0 |
C000005587 overview: performance, fees, allocation and SEC filings